Staff Members - Benha University
Serum YKL40: A novel potential link between inflammation and dyslipidemia in acne vulgaris
• 2019
Publication Information
Authors
Adel Ebrahim MD1 | Amany Ibrahim Mustafa MD1 | Ola Samir El‐Shimi MD2 |
Mai Abdallah Fathy MBBCh3
Keywords
acne vulgaris, dyslipidemia, YKL‐40
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Acne vulgaris (AV) is an inflammatory skin disorder that may be associated
with metabolic disorders. The relation between lipid profile in acne is not widely
investigated. Chitinase‐3‐like protein 1 (YKL‐40) has been found to be implicated in
different inflammatory conditions.
Aims: We aimed at investigating the role YKL‐40 in acne pathogenesis and associated
dyslipidemia in acne patients.
Patients/Methods: This study included 50 acne vulgaris patients and 30 matched
control subjects. Serum YKL‐40 in addition to lipid profile were assessed in all studied
subjects.
Results: Serum YKL‐40 level was significantly elevated in acne patients than healthy
controls (P < .001). We also found a significant positive correlations between serum
YKL‐40, serum TGs, TC, and LDL‐C (P value: .022, .001, .017 respectively) while, a
significant negative correlation between serum YKL‐40 and HDL‐c (P value: .036)
was detected.
Conclusion: Our study results suggest that YKL‐40 might have a role in AV pathogenesis.
In addition, it could provide a new potential link between inflammation and
dyslipidemia observed in acne patients.
with metabolic disorders. The relation between lipid profile in acne is not widely
investigated. Chitinase‐3‐like protein 1 (YKL‐40) has been found to be implicated in
different inflammatory conditions.
Aims: We aimed at investigating the role YKL‐40 in acne pathogenesis and associated
dyslipidemia in acne patients.
Patients/Methods: This study included 50 acne vulgaris patients and 30 matched
control subjects. Serum YKL‐40 in addition to lipid profile were assessed in all studied
subjects.
Results: Serum YKL‐40 level was significantly elevated in acne patients than healthy
controls (P < .001). We also found a significant positive correlations between serum
YKL‐40, serum TGs, TC, and LDL‐C (P value: .022, .001, .017 respectively) while, a
significant negative correlation between serum YKL‐40 and HDL‐c (P value: .036)
was detected.
Conclusion: Our study results suggest that YKL‐40 might have a role in AV pathogenesis.
In addition, it could provide a new potential link between inflammation and
dyslipidemia observed in acne patients.